Therapy Areas: Cardiovascular
Conformal Medical names new director
20 November 2020 - United States-based Conformal Medical Inc has named George Fazio as its new director, it was reported on Thursday.Presently, Fazio is the president and chief executive officer of Co...
Phoenix Biotechnology Inc announces Oleandrin's antiviral activity against SARS-CoV-2
20 November 2020 - Drug company Phoenix Biotechnology Inc stated on Thursday that that the "Antiviral Effects of Oleandrin" article published in the Journal of Experimental Pharmacology emph...
Moderna Inks Supply Agreement with United Kingdom government to Supply mRNA Vaccine Against COVID-19 if Approved for Use
18 November 2020 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) has inked a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine c...
Canon Medical Provides Resource Guide for Using Ultrasound to Manage COVID-19 Patients
18 November 2020 - - Japanese optical, imaging, and industrial products provider Canon's (OTC: CAJFF) Canon Medical Systems USA, Inc. business is offering a resource to help them more effect...
HealthCore Coordinating First US Longitudinal Study to Understand New COVID-19 Pediatric Syndrome with Greater Impact on Black and Latino Children
16 November 2020 - - US-based HealthCore, an outcomes research company of Anthem, Inc., is managing a new study to help understand and combat the pediatric public health emergency arising from the COV...
UK government to open two new 'megalabs' for COVID-19 tests in Britain in early 2021
16 November 2020 - The UK government will open two new laboratories in Britain in early 2021 that will more than double the country's capacity for carrying out COVID-19 tests, Reuters news agency...
Related Headlines

Alnylam Touts Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension

Akero Therapeutics reports first nine months 2020 financial results

Medicure reports financial results for nine months ended 30 September 2020

Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273)

Reven Pharmaceuticals Touts Positive Results Regarding the Clinical Safety and Preclinical Efficacy of Its COVID-19 Drug Candidate Rejuveinix

Bristol Myers Squibb Presents Late-Breaking Phase 2 Data Demonstrating the Safety and Efficacy of Deucravacitinib in Patients with Psoriatic Arthritis

Vifor Pharma and Angion Biomedica Corp enter into licensing agreement for ANG-3777 to treat delayed graft function and cardiac surgery-associated acute kidney injury

AstraZeneca's Brilinta Approved in the US to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Pfizer Initiates a Phase 2b Clinical Study of Vupanorsen

Agarwal Joins Dr. Reddy's Laboratories as Chief Financial Officer

COVID-19 Immune Response Study Could Lead to More Effective Treatments

Dr. Reddy's Partners On Sputnik V vaccine Clinical Trials in India

Regeneron's COVID-19 antibody treatment shown to cut medical visits in a clinical trial

Amgen Completes Discussions for Systemic Lupus Erythematosus Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs Pilot Program

UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna's mRNA Vaccine Against COVID-19